YahooSeptember 16, 2026 at 6:53 AM NYLast Month
Alvotech Shares Rise 5.6% After Barclays Upgrades Rating and Doubles Price Target
Alvotech (NASDAQ:ALVO) shares gained 5. 6% in premarket trading after Barclays upgraded the biosimilar drug developer from Underweight to Overweight and raised its price target from $4.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
